CClinicalTrials.gg
CompletedNCT02279043Updated Mar 19, 2019Results posted

Online Peer Influence on IUD Behaviors and Attitudes

An interventional study of Interaction with users of IUC and non-IUC users and Interaction with non-IUC users only in Contraception, sponsored by University of California, San Francisco. Completed at 1 site in United States. Open to female participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-03-19.

Sponsored by University of California, San Francisco · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
630
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
Female
01

Study summary

This study will look at women's social communication about IUDs (intrauterine devices) and their attitudes and behavior related to IUD use. The researchers will design an online community where women can talk to each other about their experiences with birth control. We will examine whether social exposure to IUD users in this setting is associated with change in attitudes and behavior among women who have never had an IUD.

Read the detailed description

Study Design:

University of Pennsylvania researchers will conduct a randomized controlled trial to examine whether there is an association between social exposure to women who use intrauterine contraception (IUC) as their method of birth control and change in IUC attitudes and behavior among women who have never used IUC. The intervention used to test this association will be an online social community, designed by the researchers, in which women will be invited to share their personal experiences with birth control methods they have used. Non-IUC user participants will be randomized to either the intervention or control conditions. The intervention condition will consist of small online social groups in which non-IUC user participants will interact with IUC user participants. The control condition will consist of online groups identical to intervention groups, except that no IUC user participants will be in these groups. Participants will interact within small groups for twelve days each. Non-IUC user participants will complete surveys before and after the twelve-day intervention that measure IUC attitudes and behavior. UCSF researchers will conduct analysis on deidentified data obtained from this study.

Hypothesis:

It is hypothesized that among women who have never used IUC, there is an association between social exposure to IUC users and change in attitudes and behavior related to IUC use. It is also hypothesized that exposure to IUC users is associated with positive change in knowledge of IUC use and efficacy and positive change in IUC-related information-seeking.

Aims:

The study has three aims:

Aim 1: To determine whether exposure to IUC users in an online community is associated with change in women's attitudes and behavior related to IUC use.

Aim 2: To determine whether an association between exposure to IUC users and change in women's IUC attitudes and behavior varies by women's race/ethnicity.

Aim 3: To observe the content of women's interactions about IUC and other birth control methods in an online social community.

Data analysis:

In order to address Aim 1, we will first conduct univariate analysis and obtain descriptive statistics (including mean, median, mode, variance, and range) on demographic characteristics and IUC attitudes and behaviors among participants in the intervention and control groups. In bivariate analysis, we will use chi-square tests to examine the relationship between study condition and IUC-related behaviors, as measured on the post-survey. We will use t-tests to examine relationships between condition and post-survey IUC attitudes, and matched t-tests to examine the relationships between conditions and changes in IUC attitudes. If data on attitudes is not normally distributed, we will use the appropriate non-parametric tests instead of t-tests.

We will conduct multivariate analyses for those outcomes associated with intervention condition in bivariate tests. Multivariate analysis for Aim 1 will include mixed-effects regression to examine associations at both the individual and cluster levels. We will use multiple linear regression for continuous outcomes and multiple logistic regression for binary outcomes. Regression models will test associations between intervention and control conditions and outcome IUC attitude and behavior variables. We will obtain regression coefficients from linear regression models and odds ratios from logistic regression models in order to describe the associations between study arms and outcomes.

In order to address Aim 2, we will examine bivariate relationships between the racial/ethnic categories of participants and outcome attitude and behavior variables, using chi-square tests for binary outcomes and t-tests or appropriate non-parametric tests for continuous outcomes. We will use multiple linear and/or logistic regression to test possible associations between race/ethnicity and outcome variables, controlling for other background variables. Resulting regression coefficients and odds ratios will describe whether the effect of the intervention was greater for women in some racial/ethnic groups as compared to others.

In order to address Aim 3, we will perform qualitative analysis of conversations that take place among group members in the online social groups, using grounded theory methodology. We will examine qualitative data from both the intervention and control groups.

Privacy:

Recruitment and participation in the study will occur online. Participants will only interact with the study from remote locations, so they will not be seen entering or leaving any location affiliated with the study, or interacting with any study personnel. Once registered in the study, participants will only be contacted via secure email that does not indicate the nature of the study in the subject line. The study website will be password-protected to prohibit access to Internet users not participating in the study. Participants' screen names on the site will not contain their real names, and they will not be identifiable to other study participants.

There is minimal risk of privacy loss. Study participants may not want others to know about their interest in or use of birth control, and may have feelings of embarrassment or shame in the event of a loss of study privacy. Additionally, birth control use may be a sensitive topic in the personal relationships of some study participants, and a loss of privacy could lead to strain or conflict in these personal relationships.

Confidentiality:

Data collected by researchers at the University of Pennsylvania will be stored on a secure network at their site. Only University of Pennsylvania study staff will have access to data on this network. University of PEnnsylvania staff will remove all identifiers from the data and export the data to researchers at UCSF via secure email. Deidentified data will be stored at on a secure UCSF server. Only the study staff will have access to the data, and we will not have access to the key.

02

Conditions studied

  • Contraception

Keywords

  • IUD
  • IUC
  • birth control
  • contraception
  • online
03

In context

Lead sponsor

University of California, San Francisco is the lead sponsor of 2,132 studies on the registry; 375 are open to participants now.

Of its 262 completed or terminated interventional studies of FDA-regulated products, 196 (75%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

Non-IUC users:

  • Women
  • Age 18 - 45
  • Sexually active with men
  • Do not want to get pregnant in the next year
  • Want to learn more about different birth control methods

IUC users

  • Women
  • Age 18-45
  • Currently uses IUC (Paragard, Mirena, or Skyla)

Exclusion criteria

Exclusion Criteria:

Non-IUC users

  • Previous IUC use
  • Not able to become pregnant

IUC users

-Using IUC for other reason, and not pregnancy prevention

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
630 participants (actual)

Study arms

  • Experimental
    Intervention

    IUC users and non-IUC user participants randomized to the intervention arm will take part in small intervention groups in an online community called Birth Control Connect for twelve days. There will be up to 35 intervention groups with 9 members each. Non-IUC users in these groups will receive the intervention of Interaction with users of IUC and non-IUC users in the context of the online community. About 50% of participants in intervention groups will be current IUC users, and 50% will not be current IUC users. We will measure the attitudes and behaviors of those who do not have IUC before and after the intervention, considering social exposure to IUC users as a possible predictor of changes in knowledge, attitude and behavior.

    Behavioral: Interaction with users of IUC and non-IUC users

  • Placebo comparator
    Control

    Participants randomized to the control arm will take part in Birth Control Connect control groups identical to those in the intervention arm, except no participants in the control arm will be current IUC users. Therefore, participants in the control arm will have interaction with non-IUC users only. We will measure these participants' attitudes and behavior related to IUC use before and after the twelve-day study period, and compare results to those of participants in the intervention arm. There will be up to 35 control groups of 9 members each.

    Behavioral: Interaction with non-IUC users only

  • No intervention
    IUC users

    IUC users will be recruited to populate intervention groups. Interaction with IUC users will be the intervention for non-IUC users randomized to the intervention arm. IUC users will receive no intervention.

Interventions

  • BehavioralInteraction with users of IUC and non-IUC users

    Birth Control Connect is an online community where women will be invited to share their personal experiences with birth control. Birth Control Connect group sessions will last for twelve days. Each day, participants will be prompted to respond to questions in the group (e.g. "If you're using a birth control method right now, how did you choose it?"). Participants will also be able to pose questions to other members of the group and respond to other members' questions. Half of participants in Birth Control Connect intervention groups will be current IUC users.

  • BehavioralInteraction with non-IUC users only

    Birth Control Connect is an online community where women will be invited to share their personal experiences with birth control. Birth Control Connect group sessions will last for twelve days. Each day, participants will be prompted to respond to questions in the group (e.g. "If you're using a birth control method right now, how did you choose it?"). Participants will also be able to pose questions to other members of the group and respond to other members' questions.

06

What researchers measure

Primary outcomes

  1. Number of Participants Reporting IUC Use

    Self-reported use of IUC in post-survey

    Time frame: 12 days post-baseline

Secondary outcomes

  1. Mean Change in Attitude About Hormonal IUC as Method for Self Between Pre-survey and Post-survey

    Mean difference of responses to scale in pre- and post-surveys asking participants to rate hormonal IUC as a contraceptive method for themselves, with 0=terrible method and 10=great method

    Time frame: 12 days post-baseline

  2. Mean Change in Attitude About Hormonal IUC as Method for Women in General Between Pre-survey and Post-survey

    Responses to scale in pre- and post-surveys asking participants to rate hormonal IUC as a contraceptive method for women in general, with 0=terrible method and 10=great method

    Time frame: 12 days post-baseline

  3. Mean Change in Attitude About Non-hormonal IUC as Method for Self Between Pre-survey and Post-survey

    Responses to scale in pre- and post-surveys asking participants to rate non-hormonal IUC as a contraceptive method for themselves, with 0=terrible method and 10=great method

    Time frame: 12 days post-baseline

  4. Mean Change in Attitude About Non-hormonal IUC as Method for Women in General Between Pre-survey and Post-survey

    Responses to scale in pre- and post-surveys asking participants to rate non-hormonal IUC as a contraceptive method for women in general, with 0=terrible method and 10=great method

    Time frame: 12 days post-baseline

  5. Number of Participants With Responses Indicating Knowledge of IUC Safety

    Response on 5-point Likert scale of agreement in post-survey on IUC safety. Dichotomized as 4 or 5 (Agree or strongly agree) vs. 1, 2, or 3 (Strongly disagree, disagree, or neither agree nor disagree). Outcome is count of participants responding 4 or 5.

    Time frame: 12 days post-baseline

  6. Number of Participants With Responses Indicating Knowledge of IUC Effectiveness

    Response on 5-point Likert scale of agreement in post-survey on IUC effectiveness. Dichotomized as 4 or 5 (Agree or strongly agree) vs. 1, 2, or 3 (Strongly disagree, disagree, or neither agree nor disagree). Outcome is count of participants responding 4 or 5.

    Time frame: 12 days post-baseline

  7. Number of Participants With Responses Indicating Knowledge of IUC Being More Effective Than Birth Control Pill

    Correct response to post-survey item asking whether IUC is more, less, or as effective as the birth control pill (correct response: more effective).

    Time frame: 12 days post-baseline

  8. Number of Participants Reporting Informational Support (Receiving New Information From Birth Control Connect)

    Response on 5-point Likert scale of agreement in post-survey on whether Birth Control Connect group gave participants information on IUC they didn't have before. Dichotomized as 4 or 5 (Agree or strongly agree) vs. 1, 2, or 3 (Strongly disagree, disagree, or neither agree nor disagree). Outcome is count of participants responding 4 or 5.

    Time frame: 12 days post-baseline

  9. Number of Participants Reporting Informational Support (Better Idea of What IUC Would be Like)

    Response on 5-point Likert scale of agreement in post-survey on whether Birth Control Connect gave them a better idea of what using IUC would be like. Dichotomized as 4 or 5 (Agree or strongly agree) vs. 1, 2, or 3 (Strongly disagree, disagree, or neither agree nor disagree). Outcome is count of participants responding 4 or 5.

    Time frame: 12 days post-baseline

  10. Number of Participants Reporting Information-seeking on Internet

    Report (Yes/No) in post-survey of whether participant had looked on the Internet (outside of Birth Control Connect) for information on IUC since study start. Outcome is count of participants reporting yes.

    Time frame: 12 days post-baseline

  11. Number of Participants Reporting Information-seeking From a Health Care Provider

    Report (Yes/No) in post-survey of whether participant had consulted a health care provider about IUC since study start. Outcome is count of participants reporting yes.

    Time frame: 12 days post-baseline

  12. Number of Participants Reporting Information-seeking From Peers

    Report (Yes/No) in post-survey of whether participant had talked to women they know about IUC since study start. Outcome is count of participants reporting yes.

    Time frame: 12 days post-baseline

07

Results

Posted Mar 11, 2019

Participant flow

Participant flow — Overall Study
MilestoneInterventionControlIUC Users
Started175315140
Completed128226140
Not completed47890
Withdrew: Post-rand. exclusion - not eligible110
Withdrew: Lost to follow-up46880

Outcome measures

PrimaryNumber of Participants Reporting IUC Use

Self-reported use of IUC in post-survey

Time frame:
12 days post-baseline
Reported as:
Count of participants · Participants
Number of Participants Reporting IUC Use
ParticipantsInterventionControl
Number of Participants Reporting IUC Use24
Statistical analysis
  • Intervention vs Control · Regression, Logistic · p = 0.89 · Odds ratio (or): 0.88 · 95% CI 0.16 to 4.88
SecondaryMean Change in Attitude About Hormonal IUC as Method for Self Between Pre-survey and Post-survey

Mean difference of responses to scale in pre- and post-surveys asking participants to rate hormonal IUC as a contraceptive method for themselves, with 0=terrible method and 10=great method

Time frame:
12 days post-baseline
Reported as:
Mean · units on a scale
Mean Change in Attitude About Hormonal IUC as Method for Self Between Pre-survey and Post-survey
units on a scaleInterventionControl
Mean Change in Attitude About Hormonal IUC as Method for Self Between Pre-survey and Post-survey0.50 (0.01 to 0.98)0.16 (-0.22 to 0.53)
Statistical analysis
  • Intervention vs Control · t-test, 2 sided · p = 0.28
SecondaryMean Change in Attitude About Hormonal IUC as Method for Women in General Between Pre-survey and Post-survey

Responses to scale in pre- and post-surveys asking participants to rate hormonal IUC as a contraceptive method for women in general, with 0=terrible method and 10=great method

Time frame:
12 days post-baseline
Reported as:
Mean · units on a scale
Mean Change in Attitude About Hormonal IUC as Method for Women in General Between Pre-survey and Post-survey
units on a scaleInterventionControl
Mean Change in Attitude About Hormonal IUC as Method for Women in General Between Pre-survey and Post-survey0.65 (0.25 to 1.04)0.05 (-0.27 to 0.38)
Statistical analysis
  • Intervention vs Control · t-test, 2 sided · p = 0.03
  • Intervention vs Control · Regression, Linear · p = 0.02 · Slope: 0.59 · 95% CI 0.08 to 1.11
SecondaryMean Change in Attitude About Non-hormonal IUC as Method for Self Between Pre-survey and Post-survey

Responses to scale in pre- and post-surveys asking participants to rate non-hormonal IUC as a contraceptive method for themselves, with 0=terrible method and 10=great method

Time frame:
12 days post-baseline
Reported as:
Mean · units on a scale
Mean Change in Attitude About Non-hormonal IUC as Method for Self Between Pre-survey and Post-survey
units on a scaleInterventionControl
Mean Change in Attitude About Non-hormonal IUC as Method for Self Between Pre-survey and Post-survey0.22 (-0.33 to 0.41)0.04 (-0.34 to 0.40)
Statistical analysis
  • Intervention vs Control · t-test, 2 sided · p = 0.59
SecondaryMean Change in Attitude About Non-hormonal IUC as Method for Women in General Between Pre-survey and Post-survey

Responses to scale in pre- and post-surveys asking participants to rate non-hormonal IUC as a contraceptive method for women in general, with 0=terrible method and 10=great method

Time frame:
12 days post-baseline
Reported as:
Mean · units on a scale
Mean Change in Attitude About Non-hormonal IUC as Method for Women in General Between Pre-survey and Post-survey
units on a scaleInterventionControl
Mean Change in Attitude About Non-hormonal IUC as Method for Women in General Between Pre-survey and Post-survey0.50 (0.08 to 0.92)0 (-0.34 to 0.34)
Statistical analysis
  • Intervention vs Control · t-test, 2 sided · p = 0.08
SecondaryNumber of Participants With Responses Indicating Knowledge of IUC Safety

Response on 5-point Likert scale of agreement in post-survey on IUC safety. Dichotomized as 4 or 5 (Agree or strongly agree) vs. 1, 2, or 3 (Strongly disagree, disagree, or neither agree nor disagree). Outcome is count of participants responding 4 or 5.

Time frame:
12 days post-baseline
Reported as:
Count of participants · Participants
Number of Participants With Responses Indicating Knowledge of IUC Safety
ParticipantsInterventionControl
Number of Participants With Responses Indicating Knowledge of IUC Safety103172
Statistical analysis
  • Intervention vs Control · Regression, Logistic · p = 0.34 · Odds ratio (or): 1.29 · 95% CI 0.75 to 2.20
SecondaryNumber of Participants With Responses Indicating Knowledge of IUC Effectiveness

Response on 5-point Likert scale of agreement in post-survey on IUC effectiveness. Dichotomized as 4 or 5 (Agree or strongly agree) vs. 1, 2, or 3 (Strongly disagree, disagree, or neither agree nor disagree). Outcome is count of participants responding 4 or 5.

Time frame:
12 days post-baseline
Reported as:
Count of participants · Participants
Number of Participants With Responses Indicating Knowledge of IUC Effectiveness
ParticipantsInterventionControl
Number of Participants With Responses Indicating Knowledge of IUC Effectiveness115203
Statistical analysis
  • Intervention vs Control · Regression, Logistic · p = 0.99 · Odds ratio (or): 1.00 · 95% CI 0.49 to 2.05
SecondaryNumber of Participants With Responses Indicating Knowledge of IUC Being More Effective Than Birth Control Pill

Correct response to post-survey item asking whether IUC is more, less, or as effective as the birth control pill (correct response: more effective).

Time frame:
12 days post-baseline
Reported as:
Count of participants · Participants
Number of Participants With Responses Indicating Knowledge of IUC Being More Effective Than Birth Control Pill
ParticipantsInterventionControl
Number of Participants With Responses Indicating Knowledge of IUC Being More Effective Than Birth Control Pill72105
Statistical analysis
  • Intervention vs Control · Regression, Logistic · p = 0.08 · Odds ratio (or): 1.48 · 95% CI 0.95 to 2.29
SecondaryNumber of Participants Reporting Informational Support (Receiving New Information From Birth Control Connect)

Response on 5-point Likert scale of agreement in post-survey on whether Birth Control Connect group gave participants information on IUC they didn't have before. Dichotomized as 4 or 5 (Agree or strongly agree) vs. 1, 2, or 3 (Strongly disagree, disagree, or neither agree nor disagree). Outcome is count of participants responding 4 or 5.

Time frame:
12 days post-baseline
Reported as:
Count of participants · Participants
Number of Participants Reporting Informational Support (Receiving New Information From Birth Control Connect)
ParticipantsInterventionControl
Number of Participants Reporting Informational Support (Receiving New Information From Birth Control Connect)81116
Statistical analysis
  • Intervention vs Control · Regression, Logistic · p = 0.03 · Odds ratio (or): 1.63 · 95% CI 1.05 to 2.58
  • Intervention vs Control · Mixed Models Analysis · p = 0.03 · Slope: 0.50 · 95% CI 0.04 to 0.97Mixed effects logistic regression
SecondaryNumber of Participants Reporting Informational Support (Better Idea of What IUC Would be Like)

Response on 5-point Likert scale of agreement in post-survey on whether Birth Control Connect gave them a better idea of what using IUC would be like. Dichotomized as 4 or 5 (Agree or strongly agree) vs. 1, 2, or 3 (Strongly disagree, disagree, or neither agree nor disagree). Outcome is count of participants responding 4 or 5.

Time frame:
12 days post-baseline
Reported as:
Count of participants · Participants
Number of Participants Reporting Informational Support (Better Idea of What IUC Would be Like)
ParticipantsInterventionControl
Number of Participants Reporting Informational Support (Better Idea of What IUC Would be Like)90116
Statistical analysis
  • Intervention vs Control · Regression, Logistic · p = <0.01 · Odds ratio (or): 2.25 · 95% CI 1.42 to 3.56
  • Intervention vs Control · Mixed Models Analysis · p = <0.01 · Slope: 0.84 · 95% CI 0.33 to 1.35Mixed effects logistic regression
SecondaryNumber of Participants Reporting Information-seeking on Internet

Report (Yes/No) in post-survey of whether participant had looked on the Internet (outside of Birth Control Connect) for information on IUC since study start. Outcome is count of participants reporting yes.

Time frame:
12 days post-baseline
Reported as:
Count of participants · Participants
Number of Participants Reporting Information-seeking on Internet
ParticipantsInterventionControl
Number of Participants Reporting Information-seeking on Internet59103
Statistical analysis
  • Intervention vs Control · Regression, Logistic · p = 0.93 · Odds ratio (or): 1.02 · 95% CI 0.52 to 2.74
SecondaryNumber of Participants Reporting Information-seeking From a Health Care Provider

Report (Yes/No) in post-survey of whether participant had consulted a health care provider about IUC since study start. Outcome is count of participants reporting yes.

Time frame:
12 days post-baseline
Reported as:
Count of participants · Participants
Number of Participants Reporting Information-seeking From a Health Care Provider
ParticipantsInterventionControl
Number of Participants Reporting Information-seeking From a Health Care Provider1015
Statistical analysis
  • Intervention vs Control · Regression, Logistic · p = 0.68 · Odds ratio (or): 1.19 · 95% CI 0.52 to 2.74
SecondaryNumber of Participants Reporting Information-seeking From Peers

Report (Yes/No) in post-survey of whether participant had talked to women they know about IUC since study start. Outcome is count of participants reporting yes.

Time frame:
12 days post-baseline
Reported as:
Count of participants · Participants
Number of Participants Reporting Information-seeking From Peers
ParticipantsInterventionControl
Number of Participants Reporting Information-seeking From Peers5687
Statistical analysis
  • Intervention vs Control · Regression, Logistic · p = 0.33 · Odds ratio (or): 1.24 · 95% CI 0.08 to 1.93

Adverse events

Collected over 12 days post-baseline. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Intervention0/175 (0%)0/175 (0%)0/175 (0%)
Control0/315 (0%)0/315 (0%)0/315 (0%)

Baseline characteristics

Data analyzed for non-IUC user participants only, not IUC users. Post-randomization excluded participants (n=2) not included in baseline analyses.

Age, Customized
Age, Customized(Participants)InterventionControlIUC UsersTotal
18-2490159—249
25-3479137—216
35-45517—22
Missing01—1
Sex: Female, Male
Sex: Female, Male(Participants)InterventionControlIUC UsersTotal
Female174314—488
Male00—0
Race/Ethnicity, Customized
Race/Ethnicity, Customized(Participants)InterventionControlIUC UsersTotal
Asian1224—36
Black/African American2238—60
Hispanic/Latina1136—47
White116185—301
Other918—27
Missing413—17
Number of pregnancies
Number of pregnancies(Participants)InterventionControlIUC UsersTotal
0 pregnancies82159—241
1 or more pregnancies2129—50
Missing71126—197
Number of children
Number of children(Participants)InterventionControlIUC UsersTotal
0 children154282—436
1 or more children2031—51
Missing01—1
Birth control method used at baseline
Birth control method used at baseline(Participants)InterventionControlIUC UsersTotal
Pill95171—266
Patch211—13
Ring1013—23
Shot1212—24
Arm implant1729—46
Condoms64110—174
Withdrawal3770—107
Female sterilization44—8
Male sterilization27—9
Other26—8
None716—23
Parental education
Parental education(Participants)InterventionControlIUC UsersTotal
High school graduate or less3151—82
Some college or 4-year college graduate56122—178
More than 4-year college graduate4153—94
Missing4688—134
08

Study locations

1 site
  • University of Pennsylvania, Annenberg School of Communication
    Philadelphia, Pennsylvania 19104, United States
09

References and documents

Individual participant data

Plan to share: No — Deidentified data will be shared with UCSF researchers through secure email.

No publications or documents are linked to this record.

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 19, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT02279043
Lead sponsor
University of California, San Francisco
Collaborators
William and Flora Hewlett Foundation, University of Pennsylvania
Responsible party
Christine Dehlendorf (Associate Professor, School of Medicine, Department of Family and Community Medicine, University of California, San Francisco) — Principal investigator
First posted
Oct 30, 2014
Start date
Oct 2015
Primary completion
Jul 2016
Completion
Jul 2016
Results posted
Mar 11, 2019
Last update
Mar 19, 2019

Study contacts

Damon Centola, PhD
principal investigator · University of Pennsylvania, Annenberg School of Communication
Christine Dehlendorf, MD, MAS
principal investigator · University of California, San Francisco

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion